News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
133,362 Results
Type
Article (5164)
Company Profile (48)
Press Release (128150)
Section
Business (49422)
Career Advice (128)
Deals (8289)
Drug Delivery (4)
Drug Development (17667)
Employer Resources (20)
FDA (3026)
Job Trends (3600)
News (76375)
Policy (5644)
Tag
Academia (398)
Allergies (14)
Alliances (6019)
Alzheimer's disease (365)
Approvals (3023)
Bankruptcy (51)
Best Places to Work (3288)
Biotechnology (37)
Breast cancer (31)
Cancer (211)
Career advice (109)
Cell therapy (34)
Clinical research (14449)
Collaboration (37)
COVID-19 (461)
Cystic fibrosis (20)
Data (283)
Diabetes (24)
Diagnostics (1441)
Earnings (35626)
Employer resources (16)
Events (21250)
Executive appointments (18)
FDA (3112)
Funding (38)
Gene therapy (17)
GLP-1 (138)
Government (759)
Healthcare (4658)
Infectious disease (467)
Inflammatory bowel disease (24)
IPO (5341)
Job creations (418)
Job search strategy (104)
Layoffs (95)
Legal (1050)
Liver cancer (14)
Lung cancer (46)
Medical device (3307)
Medtech (3307)
Mergers & acquisitions (2959)
Metabolic disorders (56)
Neuroscience (414)
NextGen Class of 2024 (1062)
Non-profit (824)
Northern California (325)
Obesity (29)
Opinion (17)
People (6402)
Phase I (3838)
Phase II (6154)
Phase III (5693)
Pipeline (191)
Postmarket research (558)
Preclinical (1327)
Radiopharmaceuticals (46)
Rare diseases (41)
Real estate (636)
Regulatory (4065)
Research institute (388)
Resumes & cover letters (17)
Schizophrenia (15)
Southern California (262)
Startups (383)
United States (2664)
Vaccines (108)
Weight loss (19)
Date
Today (92)
Last 7 days (348)
Last 30 days (721)
Last 365 days (7798)
2024 (6972)
2023 (12425)
2022 (25888)
2021 (10841)
2020 (9929)
2019 (8582)
2018 (6336)
2017 (5599)
2016 (5006)
2015 (6429)
2014 (4391)
2013 (3098)
2012 (3475)
2011 (3626)
2010 (3374)
Location
Africa (92)
Arizona (16)
Asia (8003)
Australia (1192)
California (659)
Canada (261)
China (44)
Colorado (35)
Connecticut (23)
Delaware (35)
Europe (18462)
Florida (100)
Georgia (18)
Illinois (43)
Indiana (51)
Kansas (15)
Maine (19)
Maryland (104)
Massachusetts (461)
Michigan (25)
Minnesota (45)
New Jersey (225)
New York (208)
North Carolina (144)
Northern California (325)
Ohio (17)
Pennsylvania (216)
South America (190)
Southern California (262)
Texas (64)
Utah (20)
Virginia (16)
Washington State (99)
133,362 Results for "26".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
EyePoint Pharmaceuticals to Host R&D Day on June 26, 2024
EyePoint Pharmaceuticals, Inc. today announced that the Company will host an R&D Day on Wednesday, June 26, 2024 from 8:00 a.m. to 9:30 a.m. ET.
June 18, 2024
·
2 min read
Press Releases
DNA Methylation Market Size to Hit USD 6.26 Billion by 2034
November 4, 2024
·
1 min read
BioMidwest
Join BioVie’s Exclusive Live Investor Webinar and Q&A Session on June 26
BioVie Inc. is pleased to invite investors to a webinar on June 26, 2024, at 4:15 p.m. ET.
June 12, 2024
·
3 min read
Business
Avantor® to Host Second Quarter 2024 Earnings Call on Friday, July 26, 2024
Avantor, Inc. announced that it will release its second quarter 2024 financial results before the market opens on Friday, July 26, and will hold a conference call on the same day at 8:00 a.m. Eastern Time to discuss the results.
June 28, 2024
·
1 min read
Genetown
Moleculent Launches with $26 Million Series A Financing to Advance the Spatial Mapping of Cell-Cell Communication
Moleculent AB, a company pioneering technology to study the communication between cells in human tissue, announced the closing of its oversubscribed $26 million Series A financing.
June 11, 2024
·
4 min read
Pharm Country
Bristol Myers Squibb to Report Results for Second Quarter 2024 on July 26, 2024
Bristol Myers Squibb (NYSE: BMY) will announce results for the second quarter of 2024 on Friday, July 26, 2024. Company executives will review financial results and address inquiries from investors and analysts during a conference call beginning at 8:00 a.m. ET on the same date.
June 20, 2024
·
1 min read
Press Releases
Silo Pharma Reports Positive Results in Sterilization and Dissolution Testing of SP-26 Ketamine Implant
October 31, 2024
·
4 min read
Calliditas Therapeutics to Present Data at ERA 2024 May 23 - 26 in Stockholm
Calliditas Therapeutics AB today announced upcoming data presentations and a sponsored symposium at the 61st European Renal Association (ERA) Congress, in Stockholm, Sweden on May 23 - 26, 2024.
May 15, 2024
·
6 min read
Drug Development
Artelo Biosciences Presents Preclinical Data on ART26.12 in Breast Cancer-Induced Bone Pain at the 34th Annual International Cannabinoid Research Society Symposium
Artelo Biosciences, Inc. today announced Professor Saoirse O’Sullivan, Vice President of Translational Sciences at Artelo, presented preclinical data related to ART26.12.
July 1, 2024
·
5 min read
Mergers & acquisitions
Lundbeck Deepens Neuro, Rare Disease Portfolio With $2.6B Longboard Buy
Under the deal, the Danish pharma will gain access to Longboard’s 5-HT2C receptor superagonist that is currently in late-stage development for seizures in various developmental and epileptic encephalopathies, including Dravet syndrome.
October 14, 2024
·
2 min read
·
Tristan Manalac
1 of 13,337
Next
